AltaThera Pharmaceuticals Competitors and Similar CompaniesClear all
AltaThera Pharmaceuticals's competitors and similar companies include Crinetics Pharmaceuticals, Alexion Pharmaceuticals, MediWound and Juvenescence.
 Crinetics Pharmaceuticals Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors. |  Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases. |  MediWound MediWound is a biotechnology company engaged in developing innovative solutions in severe burn and chronic wound care. |  Juvenescence Juvenescence is a biotech longevity company that develops therapies and products targeting aging.
| ||
Founding Date | Founding Date 2009 | Founding Date 2008 | Founding Date 1992 | Founding Date 2001 | Founding Date 2016 |
Type | Type Private | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Chicago, US HQ | Locations San Diego, US HQ | Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more | Locations Yavne, IL HQ Rüsselsheim Am Main, DE Wilmington, US | Locations Dublin, IE HQ |
Employees | Employees 462% increase | Employees 43751% increase | Employees 10,6006% increase | Employees 111 | Employees 3310% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 5.1 b | Valuation ($) 40.3 b | Valuation ($) 196.3 m | Valuation ($) 500 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $7.7m (FY, 2025) | Revenue (est.) $6.1b (FY, 2020) | Revenue (est.) $17m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $1.1m (FY, 2025) | Cost of goods $553.5m (FY, 2020) | Cost of goods $13.1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $6.6m (FY, 2025) | Gross profit $5.5b (FY, 2020) | Gross profit $4.1m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income ($465.3m) (FY, 2025) | Net income $603.4m (FY, 2020) | Net income ($23.9m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 1m (almost 11 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 100m (almost 7 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 41.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 162.3m |
For sources of this data, please see the company profile
View Company Profiles
Crinetics Pharmaceuticals
HQ
San Diego, US
Employees
437
Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors.
View companyAlexion Pharmaceuticals
HQ
Boston, US
Employees
10,600↑ 6% increase
Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.
View companyMediWound
HQ
Yavne, IL
Employees
111
MediWound is a biotechnology company engaged in developing innovative solutions in severe burn and chronic wound care.
View companyJuvenescence
HQ
Dublin, IE
Employees
33↑ 10% increase
Juvenescence is a biotech longevity company that develops therapies and products targeting aging.
View company